PTSM: Pharmaceutical Technology Sourcing and Management, Jul 11, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
PTSM: Pharmaceutical Technology Sourcing and Management, Jul 11, 2012
Biologics
Biosimilars: Market Weaknesses and Strengths
By Patricia Van Arnum
Biosimilars represent an emerging niche in the biopharmaceutical market, but how strong is their true potential?
Outsourcing
Biomanufacturing Innovation
By Eric Langer
Industry wants more innovation, but can suppliers meet customer needs?
Global Feature
What is Ahead in Chemical API Manufacturing
By Patricia Van Arnum
Flow chemistry and microreactors offer an alternative to traditional batch manufacturing.
New Models in Contract Services
By Patricia Van Arnum
Sponsor companies' increasing focus on strategic outsourcing has changed the rules of the game.
Decades of Change for the Top Pharmaceutical Companies
By Patricia Van Arnum
Tracking change from spinoffs of chemical companies to life-sciences powerhouses.
A Look into the Future: The Pharmaceutical Company of 2020
By Patricia Van Arnum
How will the pharmaceutical company of 2020 be different from the pharmaceutical company of 2010? A look at emerging business models and the factors influencing the direction of the global pharmaceutical industry.
CSR and Sustainability Forum
The UN at the Sustainability Table
By Patricia Van Arnum
Highlights of UN Conference on Sustainable Development, held in Rio de Janeiro, Brazil, last month and related industry initiatives.
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here